Clinical Model Predicts Outcomes in Unresectable Liver Cancer
A multicentre study developed and validated a FIT model combining fibrin degradation products, serum iron, and tumour burden score to predict survival in patients with unresectable hepatocellular carcinoma receiving combined therapy.